Patents by Inventor Naoaki Yokoyama

Naoaki Yokoyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine preparation for neospora caninum infection
    Patent number: 8821882
    Abstract: A vaccine preparation characterized in that Neospora caninum-derived dense granule protein 7 or apical membrane antigen 1 or an immunologically active variant or derivative thereof is included in liposomes each having an oligosaccharide capable of binding to a carbohydrate recognition molecule on the surface of antigen-presenting cells on the surface of the liposome.
    Type: Grant
    Filed: September 11, 2009
    Date of Patent: September 2, 2014
    Assignees: Obihiro University of Agriculture and Veterinary Medicine, Tokai University Educational System
    Inventors: Yoshifumi Nishikawa, Naoaki Yokoyama, Naoya Kojima
  • Tick galectin
    Patent number: 8057801
    Abstract: A novel galectin, a polynucleotide encoding the same, a vector and a transformant comprising the polynucleotide, an antibody against the galectin, and a screening method for screening a substance capable of modifying the galectin, are disclosed. According to the galectin, polynucleotide, or vector, it is possible, for example, to exterminate ticks, or to treat or prevent tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis.
    Type: Grant
    Filed: April 21, 2009
    Date of Patent: November 15, 2011
    Assignees: Meiji Seika Kaisya Ltd.
    Inventors: Kozo Fujisaki, Hideyuki Nagasawa, Ikuo Igarashi, Hiroshi Suzuki, Chihiro Sugimoto, Gakunan Gen, Kimie Kadota, Noboru Inoue, Naoaki Yokoyama, Naotoshi Tsuji
  • Vaccine Preparation for Neospora Caninum Infection
    Publication number: 20110250265
    Abstract: A vaccine preparation characterized in that Neospora caninum-derived dense granule protein 7 or apical membrane antigen 1 or an immunologically active variant or derivative thereof is included in liposomes each having an oligosaccharide capable of binding to a carbohydrate recognition molecule on the surface of antigen-presenting cells on the surface of the liposome.
    Type: Application
    Filed: September 11, 2009
    Publication date: October 13, 2011
    Inventors: Yoshifumi Nishikawa, Naoaki Yokoyama, Naoya Kojma
  • TICK GALECTIN
    Publication number: 20100196407
    Abstract: A novel galectin, a polynucleotide encoding the same, a vector and a transformant comprising the polynucleotide, an antibody against the galectin, and a screening method for screening a substance capable of modifying the galectin, are disclosed. According to the galectin, polynucleotide, or vector, it is possible, for example, to exterminate ticks, or to treat or prevent tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis.
    Type: Application
    Filed: April 21, 2009
    Publication date: August 5, 2010
    Applicants: MEIJI FUJISAKI KAISHA, LTD.
    Inventors: Kozo Fujisaki, Hideyuki Nagasawa, Ikuo Igarashi, Hiroshi Suzuki, Chihiro Sugimoto, Gakunan Gen, Kimie Kadota, Noboru Inoue, Naoaki Yokoyama, Naotoshi Tsuji
  • Tick galectin
    Patent number: 7547682
    Abstract: A novel galectin, a polynucleotide encoding the same, a vector and a transformant comprising the polynucleotide, an antibody against the galectin, and a screening method for screening a substance capable of modifying the galectin, are disclosed. According to the galectin, polynucleotide, or vector, it is possible, for example, to exterminate ticks, or to treat or prevent tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis.
    Type: Grant
    Filed: September 22, 2006
    Date of Patent: June 16, 2009
    Assignees: Meiji Seika Kaisha, Ltd.
    Inventors: Kozo Fujisaki, Hideyuki Nagasawa, Ikuo Igarashi, Hiroshi Suzuki, Chihiro Sugimoto, Gakunan Gen, Kimie Kadota, Noboru Inoue, Naoaki Yokoyama, Naotoshi Tsuji
  • Tick galectin
    Publication number: 20070021596
    Abstract: A novel galectin, a polynucleotide encoding the same, a vector and a transformant comprising the polynucleotide, an antibody against the galectin, and a screening method for screening a substance capable of modifying the galectin, are disclosed. According to the galectin, polynucleotide, or vector, it is possible, for example, to exterminate ticks, or to treat or prevent tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis.
    Type: Application
    Filed: September 22, 2006
    Publication date: January 25, 2007
    Inventors: Kozo Fujisaki, Hideyuki Nagasawa, Ikuo Igarashi, Hiroshi Suzuki, Chihiro Sugimoto, Gakunan Gen, Kimie Kadota, Noboru Inoue, Naoaki Yokoyama, Naotoshi Tsuji
  • Mite galectin
    Patent number: 7135552
    Abstract: A novel galectin, a polynucleotide encoding the same, a vector and a transformant comprising the polynucleotide, an antibody against the galectin, and a screening method for screening a substance capable of modifying the galectin, are disclosed. According to the galectin, polynucleotide, or vector, it is possible, for example, to exterminate ticks, or to treat or prevent tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis.
    Type: Grant
    Filed: February 28, 2003
    Date of Patent: November 14, 2006
    Assignees: Meji Seika Kaisha, Ltd.
    Inventors: Kozo Fujisaki, Hideyuki Nagasawa, Ikuo Igarashi, Hiroshi Suzuki, Chihiro Sugimoto, Gakunan Gen, Kimie Kadota, Noboru Inoue, Naoaki Yokoyama, Naotoshi Tsuji
  • Mite galectin
    Publication number: 20050106677
    Abstract: A novel galectin, a polynucleotide encoding the same, a vector and a transformant comprising the polynucleotide, an antibody against the galectin, and a screening method for screening a substance capable of modifying the galectin, are disclosed. According to the galectin, polynucleotide, or vector, it is possible, for example, to exterminate ticks, or to treat or prevent tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis.
    Type: Application
    Filed: February 28, 2003
    Publication date: May 19, 2005
    Inventors: Kozo Fujisaki, Hideyuki Nagasawa, Ikuo Igarashi, Hiroshi Suzuki, Chihiro Sugimoto, Gakunan Gen, Kimie Kadota, Noboru Inoue, Naoaki Yokoyama, Naotoshi Tsuji